Capital Markets

Since 1996, Bryan Garnier & Co has established itself as one of the leading specialists in European growth sectors and companies.

Leveraging an equity research team based in London and in Paris, our expertise is a fundamental bottom-up approach applied to a well-defined universe of growth companies. We cover a broad range of small to large market capitalisations, within our five core sectors of focus (TMT, Healthcare, Consumer Brands & Retail, Renewables & Environment, Business Services & Outsourcing). They altogether represent over 50% of the total European market capitalisation.

Equity Research

Our Equity Research team tracks close to 200 stocks across our European Equity Growth universe. This highly-focused approach enables the generation of Buy and Sell recommendations for companies where the team has strong convictions. Our analysts have clear-cut opinions and publish close to 100 initiation reports and major updates per year.

Institutional Sales

Bryan, Garnier & Co is a dynamic pan-European investment bank, focused on “growth.” As such, our institutional sales and trading teams enjoy privileged relationships with a wide variety of asset managers who are typically “growth” oriented, and focused on Europe.

Derivatives Sales & Trading

In 2011, Bryan Garnier & Co developed its derivative activity, advising clients on investment decisions by tailor-made research notes and trading ideas covering  equity derivatives (options & futures) synthetic products, fixed income and foreign exchange.

Receive Alerts

Enter your email to receive our news and offers.

Cartagena Capital Merges with Bryan, Garnier & Co